NexgenRx: Top 25 Undervalued Dividend Stocks on TSX-V (NXG)
NexgenRx is now ranked among the top 25 undervalued dividend-paying stocks on the TSX Venture Exchange (TSXV). A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company. Valuation methodology provided by Stockcalc (see below).
All data provided as-at market close June 13, 2023. The list is sorted by stocks with the greatest percentage difference between valuation and price. Companies included above paid a dividend in the last 12-months. NexgenRx NexgenRx Inc administers, adjudicates and pays drug, dental and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers using proprietary computer software and provides ancillary services. NexgenRx is listed under NXG on the TSX Venture Exchange.
| Symbol | Name | Close Price | Shares Outstanding | P/E | P/B | Cash per Share | Net Cash per Share |
|---|---|---|---|---|---|---|---|
| ALV-X | Alvopetro Energy | 9.59 | 0 | 8.1 | 0 | 0 | 0 |
| BCF-X | Builders Capital Mortgage | 8.7 | 0 | 9.2 | 0 | 0 | 0 |
| FCA-U-X | Firm Capital Apartment | 3.06 | 0 | 0 | 0 | 0 | 0 |
| NXLV-X | NexLiving Communities | 0.13 | 0 | 3.7 | 0 | 0 | 0 |
| FDI-X | Findev | 0.41 | 0 | 8.3 | 0 | 0 | 0 |
| NXG-X | NexgenRx | 0.32 | 0 | 0 | 0 | 0 | 0 |
| MAR-UN-X | Marwest Apartment | 0.64 | 0 | 1.2 | 0 | 0 | 0 |
| FCA-UN-X | Firm Capital Apartment | 4.5 | 0 | 0 | 0 | 0 | 0 |
| TII-X | Terra Firma Cap | 6.24 | 0 | 17.3 | 0 | 0 | 0 |
| PINE-UN-X | Pine Trail | 0.05 | 0 | 0 | 0 | 0 | 0 |
More about NexgenRx
Stocks in this category are held primarily for potential income and capital appreciation. Dividend stocks showing a higher valuation than their current price have both potential upside and ability to sustain or grow their dividend.
Artificial intelligence at Report on Business
AI at The Globe and Mail This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.
